Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
SMP-190 by Xiling Lab for Solid Tumor: Likelihood of Approval
SMP-190 is under clinical development by Xiling Lab and currently in Phase I for Solid Tumor. According to GlobalData, Phase...